Spine Ablation in 2023: Indications, Goals, Guidelines, Evidence, an…

Jason Levy

CAR T-Cell vs. Bispecific Therapies for Blood Cancers: How Oncologis…

GRACE

A. Goodman, A. Jeong, S. Rajeeve

Endocrine Adverse Events From Checkpoint Inhibitors

Yale Cancer Center

K. Herold

ESMO 2024 Summary: Latest Advances in Targeted Therapies for Pancrea…

2024 ESMO Annual Meeting Insights Hub

D. Melisi

Tumor-Agnostic Efficacy & Safety of Selpercatinib in RET Fusion+ Sol…

UCSF School of Medicine

H. Kang

Cellular Therapy in 2024: What, Why, When, Who… and Where Are We Goi…

University of Colorado Department of Medicine

J. Gutman

ASCO® 2024 Summary: "Advancing GI Cancer Treatment - The Clinical Ut…

2024 ASCO® Annual Meeting Insights Hub

S. Cohen

Targeting KRAS in Pancreatic Cancer

Harshabad Singh

CAR T-Cell Therapy in Autoimmune Disorders

Vanderbilt University Medical Center (VUMC)

O. Oluwole

2024 Updates on Targeted Approaches for GI Cancers and New Data in N…

Total Health

A. Grothey

CAR T-Cell Therapy Side Effects for Blood Cancers

GRACE

A. Goodman

ASCO® 2024 Insights: "EXPEL-PANC - A Ph2 Study of BXCL701 + Pembro i…

2024 ASCO® Annual Meeting Insights Hub

B. Weinberg

CAR NK Cells: Next Generation Cell Therapies for Cancer

University of Colorado Cancer Center

K. Rezvani

The Improbable History of CAR T-Cells

Penn Medicine Cellicon Valley '23: The Future of Cell and Gene Therapies

C. June

The TAPUR Study: Evaluating Targeted Therapies Based on Genetic Alte…

University of Miami Sylvester Comprehensive Cancer Center

R. Schilsky

ESMO GI 2024 Insights: Role of Personalized Medicine in Pancreatic C…

Insights from 2024 ESMO GI Annual Meeting

T. Seufferlein

Interventional Delivery of CAR-T Therapy

Michael Soulen

Pancreatic Cancer Updates From Yale Cancer Center

Yale Cancer Center

J. Lacy

Latest Treatment Strategies and Standard of Care for Pancreatic Canc…

MedNews Week

M. Pishvaian

Pancreatic Adenocarcinoma and Neuroendocrine Tumors - An Update

AdventHealth

M. Tejani